Temporal evolution and inter-patient heterogeneity in primary and recurrent head and neck squamous cell carcinoma
Our results underline the importance of analysing multiple samples per patient to obtain a more complete picture of the patient's tumour and advocate a re-biopsy in the event of recurrence and treatment failure, in order to select the most appropriate therapeutic strategy.
Authors
- Alessandra Gargano (ORCID: https://orcid.org/0000-0001-9030-6430)
- Hisham Mehanna (ORCID: https://orcid.org/0000-0002-5544-6224)
- Barbara Schrörs (ORCID: https://orcid.org/0000-0001-9758-250X)
- Christian Schuster (ORCID: https://orcid.org/0000-0002-5851-5643)
- Özlem Akilli‐Öztürk
- Julia Powers Becker
- Luisa Bresadola (ORCID: https://orcid.org/0000-0002-8993-8323)
- Fulvia Vascotto (ORCID: https://orcid.org/0000-0002-9839-3484)
- Anthony Kong (ORCID: https://orcid.org/0000-0002-3989-3948)
- Uğur Şahin (ORCID: https://orcid.org/0000-0003-0363-1564)
- Valesca Bukur
- Christoph Ritzel
- David Weber (ORCID: https://orcid.org/0000-0001-9631-8459)
- Martin Löwer
Institutions
- King's College London (GB)
- Johannes Gutenberg University Mainz (DE)
- Anthony Nolan (GB)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Helmholtz Institute Mainz (DE)
Publication Details
- Journal
- BJC Reports
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1038/s44276-024-00091-5
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.42